NAT - Position papers

Displaying 1 - 3 of 3
  • Sprejeta on 15/07/2020 - Bureau decision date: 22/06/2020
    Referenca
    NAT/797-EESC-2020-01-01-2020-03040
    EESC opinion: GMO medicinal products / COVID-19
  • Sprejeta on 10/06/2020 - Bureau decision date: 04/05/2020
    Referenca
    NAT/795-EESC-2020-01-01
    Employers - GR I
    France
    EESC opinion: Support under EAFRD in response to the COVID-19 outbreak
  • Sprejeta on 05/05/2020 - Bureau decision date: 06/04/2020
    Referenca
    NAT/783-EESC-01726-00-01-pac-TRA
Displaying 1 - 3 of 3